Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1985 1
1986 1
1987 1
1990 1
1992 1
1995 2
1996 2
1998 2
1999 1
2000 1
2001 3
2002 1
2004 2
2005 1
2008 5
2009 5
2010 6
2011 19
2012 18
2013 16
2014 16
2015 15
2016 14
2017 19
2018 14
2019 16
2020 14
2021 14
2022 11
2023 8
2024 10
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

210 results

Results by year

Filters applied: . Clear all
Page 1
Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening.
Quintero E, Castells A, Bujanda L, Cubiella J, Salas D, Lanas Á, Andreu M, Carballo F, Morillas JD, Hernández C, Jover R, Montalvo I, Arenas J, Laredo E, Hernández V, Iglesias F, Cid E, Zubizarreta R, Sala T, Ponce M, Andrés M, Teruel G, Peris A, Roncales MP, Polo-Tomás M, Bessa X, Ferrer-Armengou O, Grau J, Serradesanferm A, Ono A, Cruzado J, Pérez-Riquelme F, Alonso-Abreu I, de la Vega-Prieto M, Reyes-Melian JM, Cacho G, Díaz-Tasende J, Herreros-de-Tejada A, Poves C, Santander C, González-Navarro A; COLONPREV Study Investigators. Quintero E, et al. Among authors: salas d. N Engl J Med. 2012 Feb 23;366(8):697-706. doi: 10.1056/NEJMoa1108895. N Engl J Med. 2012. PMID: 22356323 Free article. Clinical Trial.
Effect of invitation to colonoscopy versus faecal immunochemical test screening on colorectal cancer mortality (COLONPREV): a pragmatic, randomised, controlled, non-inferiority trial.
Castells A, Quintero E, Bujanda L, Castán-Cameo S, Cubiella J, Díaz-Tasende J, Lanas Á, Ono A, Serra-Burriel M, Frías-Arrocha E, Hernández C, Jover R, Andreu M, Carballo F, Morillas JD, Salas D, Almazán R, Alonso-Abreu I, Banales JM, Hernández V, Portillo I, Vanaclocha-Espí M, de la Vega M; COLONPREV study investigators. Castells A, et al. Among authors: salas d. Lancet. 2025 Apr 12;405(10486):1231-1239. doi: 10.1016/S0140-6736(25)00145-X. Epub 2025 Mar 27. Lancet. 2025. PMID: 40158525 Clinical Trial.
COVID pandemic: updates from Cuba.
Salas D. Salas D. Dialect Anthropol. 2020;44(3):233-237. doi: 10.1007/s10624-020-09607-0. Epub 2020 Aug 13. Dialect Anthropol. 2020. PMID: 35194295 Free PMC article. No abstract available.
Interim Effectiveness Estimates of 2024 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Hospitalization - REVELAC-i Network, Five South American Countries, March-July 2024.
Zeno EE, Nogareda F, Regan A, Couto P, Rondy M, Jara J, Voto C, Rojas Mena MP, Katz N, Del Valle Juarez M, Benedetti E, de Paula Júnior FJ, Ferreira da Almeida WA, Hott CE, Ferrari PR, Mallegas NV, Vigueras MA, Domínguez C, von Horoch M, Vazquez C, Silvera E, Chiparelli H, Goni N, Castro L, Marcenac P, Kondor RJ, Leite J, Velandia M, Azziz-Baumgartner E, Fowlkes AL, Salas D; REVELAC-i Network. Zeno EE, et al. Among authors: salas d. MMWR Morb Mortal Wkly Rep. 2024 Oct 3;73(39):861-868. doi: 10.15585/mmwr.mm7339a1. MMWR Morb Mortal Wkly Rep. 2024. PMID: 39361525 Free PMC article.
[Evidence on the prevention of cancer].
Salas D, Peiró R. Salas D, et al. Rev Esp Sanid Penit. 2013;15(2):66-75. doi: 10.4321/S1575-06202013000200005. Rev Esp Sanid Penit. 2013. PMID: 23843144 Free article. Review. Spanish.
210 results